Thyrocare Technologies Ltd.
| BSE: 539871 | Sector: Health care |
| NSE: THYROCARE | ISIN Code: INE594H01019 |
| BSE 00:00 | 05 Mar | 904.95 |
-9.95 (-1.09%) |
OPEN
914.90 |
HIGH
914.90 |
LOW
900.95 |
| NSE 00:00 | 05 Mar | 904.95 |
-14.05 (-1.53%) |
OPEN
917.80 |
HIGH
917.80 |
LOW
900.00 |
| OPEN | 914.90 |
| PREVIOUS CLOSE | 914.90 |
| VOLUME | 2662 |
| 52-Week high | 1212.00 |
| 52-Week low | 410.00 |
| P/E | 47.38 |
| Mkt Cap.(Rs cr) | 4,784 |
| Buy Price | 901.00 |
| Buy Qty | 51.00 |
| Sell Price | 904.95 |
| Sell Qty | 14.00 |
Thyrocare Technologies Ltd. (THYROCARE) - Latest News & Headlines
-
Testing recovery gains factored in Thyrocare Technologies stock
11.57 pm | 12 Jan 2021 | Business Standard
Margin pressures and valuations would limit major upsides
-
MARKETS: Indices end at record closing peaks; Nifty settles above 13,000
4.07 pm | 24 Nov 2020 | Business Standard
All that happened in the markets today
-
Dr Lal PathLabs, Metropolis: Here's how healthcare stocks look on charts
11.51 am | 24 Nov 2020 | Business Standard
Thyrocare Technologies has the strong support of 50-DMA, currently placed at Rs 988 levels.
-
Dr Lal PathLabs, Thyrocare slip on profit booking on Covid vaccine optimism
11.43 am | 10 Nov 2020 | Business Standard
From March lows, the stock price of Thyrocare Technologies has been more-than-tripled and of Dr Lal PathLabs more-than-doubled on the BSE
-
Thyrocare rallies 10%, hits record high on expectation of strong Q2 results
12.06 pm | 26 Oct 2020 | Business Standard
Earlier this month, the company reported nearly 37 per cent year-on-year and over 100 per cent sequential growth in aggregate revenue for Q2FY21
-
Diagnostics players post healthy returns on quick rebound in business
10.17 pm | 7 Oct 2020 | Business Standard
Sharp rise in non-Covid business and strong revenue growth indicated by Thyrocare, Metropolis prop up sentiment
-
Thyrocare, Dr Lal PathLabs: Healthcare stocks can rally more, charts show
2.10 pm | 7 Oct 2020 | Business Standard
A new all time high shows bullish sentiment is here to stay in these stocks.
-
Healthcare services stocks rally; Thyrocare up 35% in 2 days post Q2 update
11.13 am | 7 Oct 2020 | Business Standard
Thyrocare Technologies, Metropolis Healthcare and Dr. Lal PathLabs, hitting their respective record highs, were up 9 per cent to 17 per cent on the BS...
-
Thyrocare surges 15% on healthy revenue growth in September quarter
2.15 pm | 6 Oct 2020 | Business Standard
The stock of healthcare services provider has now surpassed its previous high of Rs 845.25 touched on August 17, 2020
-
Thyrocare Tech surges 5% after Co authorises Dr. A Velumani to appoint CEO
12.00 pm | 11 Sep 2020 | Business Standard
The Board has also authorised Dr. A Velumani to identify a competent candidate for the position of Managing Director, CFO, and CIO.
Quick Links for Thyrocare Technologies:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
